Insights from 2023 ASH Annual Meeting


 

ASH 2023 Insights: "MATTERHORN Study - Efficacy & Safety of Roxadustat for Treatment of Anemia in Patients With LR-MDS With Low RBC Transfusion Burden"

49 views
December 19, 2023
0 Comments
Login to view comments. Click here to Login
MDS and MPN